Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Attiyeh EF"" wg kryterium: Autor


Tytuł:
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Autorzy:
Park JR
Villablanca JG
London WB
Gerbing RB
Haas-Kogan D
Adkins ES
Attiyeh EF
Maris JM
Seeger RC
Reynolds CP
Matthay KK
Park, Julie R
Villablanca, Judith G
London, Wendy B
Gerbing, Robert B
Haas-Kogan, Daphne
Adkins, E Stanton
Attiyeh, Edward F
Maris, John M
Seeger, Robert C
Pokaż więcej
Źródło:
Pediatric Blood & Cancer; Jan2009, Vol. 52 Issue 1, p44-50, 7p
Czasopismo naukowe
Tytuł:
Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.
Autorzy:
Chang X; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Zhao Y; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Hou C; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Glessner J; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
McDaniel L; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Diamond MA; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Thomas K; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Li J; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Wei Z; Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
Liu Y; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Guo Y; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Mentch FD; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Qiu H; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Kim C; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Evans P; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Vaksman Z; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Diskin SJ; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Attiyeh EF; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Sleiman P; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Maris JM; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. .; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. .
Hakonarson H; The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. .; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. .; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2017 Sep 18; Vol. 8 (1), pp. 569. Date of Electronic Publication: 2017 Sep 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Deletion*
Matrix Metalloproteinase 20/*genetics
Neuroblastoma/*genetics
Case-Control Studies ; Cell Line, Tumor ; Chromosomes, Human, Pair 1 ; Chromosomes, Human, Pair 11 ; Genome-Wide Association Study ; Humans ; Quantitative Trait Loci ; Exome Sequencing
SCR Disease Name:
Chromosome 11q partial deletion
Czasopismo naukowe
Tytuł:
Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program.
Autorzy:
Attiyeh EF
Maris JM; Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania.
Lock R; Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia.
Reynolds CP; Texas Tech University Health Sciences Center, Lubbock, Texas.
Kang MH; Texas Tech University Health Sciences Center, Lubbock, Texas.
Carol H; Children's Cancer Institute Australia for Medical Research, Randwick, New South Wales, Australia.
Gorlick R; The Children's Hospital at Montefiore, Bronx, New York.
Kolb EA; A.I. duPont Hospital for Children, Wilmington, Delaware.
Keir ST; Duke University Medical Center, Durham, North Carolina.
Wu J; St. Jude Children's Research Hospital, Memphis, Tennessee.
Landesman Y; Karyopharm Therapeutics, Newton, Massachusetts.
Shacham S; Karyopharm Therapeutics, Newton, Massachusetts.
Lyalin D; Nationwide Children's Hospital, Columbus, Ohio.
Kurmasheva RT; Nationwide Children's Hospital, Columbus, Ohio.
Houghton PJ; Nationwide Children's Hospital, Columbus, Ohio.
Smith MA; Cancer Therapy Evaluation Program, NCI, Bethesda, Maryland.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2016 Feb; Vol. 63 (2), pp. 276-86. Date of Electronic Publication: 2015 Sep 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antineoplastic Agents/*pharmacology
Hydrazines/*pharmacology
Karyopherins/*antagonists & inhibitors
Neoplasms, Experimental/*drug therapy
Receptors, Cytoplasmic and Nuclear/*antagonists & inhibitors
Triazoles/*pharmacology
Animals ; Cell Line, Tumor ; Female ; Humans ; Inhibitory Concentration 50 ; Mice ; Mice, SCID ; Xenograft Model Antitumor Assays ; Exportin 1 Protein
Czasopismo naukowe
Tytuł:
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis.
Autorzy:
Schnepp RW; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Khurana P; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Attiyeh EF; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Raman P; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Chodosh SE; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Oldridge DA; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Gagliardi ME; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Conkrite KL; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Asgharzadeh S; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Seeger RC; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Madison BB; Division of Gastroenterology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA.
Rustgi AK; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: .
Diskin SJ; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2015 Nov 09; Vol. 28 (5), pp. 599-609. Date of Electronic Publication: 2015 Oct 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Aurora Kinase A/*genetics
Neuroblastoma/*genetics
RNA-Binding Proteins/*genetics
Signal Transduction/*genetics
ran GTP-Binding Protein/*genetics
Aurora Kinase A/metabolism ; Blotting, Western ; Carcinogenesis/genetics ; Cell Line, Tumor ; Child ; Chromosomes, Human, Pair 12/genetics ; DNA Copy Number Variations ; Gene Amplification ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; MicroRNAs/genetics ; Molecular Chaperones/genetics ; Molecular Chaperones/metabolism ; N-Myc Proto-Oncogene Protein ; Neuroblastoma/metabolism ; Neuroblastoma/pathology ; Nuclear Pore Complex Proteins/genetics ; Nuclear Pore Complex Proteins/metabolism ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Oligonucleotide Array Sequence Analysis ; Oncogene Proteins/genetics ; Oncogene Proteins/metabolism ; RNA-Binding Proteins/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; ran GTP-Binding Protein/metabolism
Czasopismo naukowe
Tytuł:
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
Autorzy:
Eleveld TF; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Oldridge DA; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Bernard V; ICGEX Platform, Institut Curie, Paris, France.
Koster J; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Colmet Daage L; 1] ICGEX Platform, Institut Curie, Paris, France. [2] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France.
Diskin SJ; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Schild L; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Bentahar NB; ICGEX Platform, Institut Curie, Paris, France.
Bellini A; Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France.
Chicard M; Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France.
Lapouble E; Unité de Génétique Somatique, Institut Curie, Paris, France.
Combaret V; Centre Léon-Bérard, Laboratoire de Recherche Translationnelle Lyon, Lyon, France.
Legoix-Né P; ICGEX Platform, Institut Curie, Paris, France.
Michon J; Département de Pédiatrie, Institut Curie, Paris, France.
Pugh TJ; Princess Margaret Cancer Centre, University Health Network; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hart LS; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Rader J; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Attiyeh EF; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Wei JS; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA.
Zhang S; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA.
Naranjo A; Department of Biostatistics, University of Florida, Children's Oncology Group (COG), Gainesville, Florida, USA.
Gastier-Foster JM; 1] The Ohio State University College of Medicine, Columbus, Ohio, USA. [2] Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Hogarty MD; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Asgharzadeh S; 1] Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA. [2] Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA. [3] Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
Guidry Auvil JM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA.
Watkins TB; Translational Cancer Therapeutics Laboratory, Cancer Research UK, London, UK.
Zwijnenburg DA; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Ebus ME; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
van Sluis P; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Hakkert A; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
van Wezel E; 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
van der Schoot CE; 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Westerhout EM; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Schulte JH; 1] Department of Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. [2] German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. [3] Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany. [4] Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.
Tytgat GA; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Dolman ME; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Janoueix-Lerosey I; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
Gerhard DS; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA.
Caron HN; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
Khan J; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA.
Versteeg R; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Schleiermacher G; 1] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. [2] Département de Pédiatrie, Institut Curie, Paris, France. [3] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.
Molenaar JJ; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Maris JM; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2015 Aug; Vol. 47 (8), pp. 864-71. Date of Electronic Publication: 2015 Jun 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Mutation*
MAP Kinase Signaling System/*genetics
Mitogen-Activated Protein Kinases/*genetics
Neoplasm Recurrence, Local/*genetics
Neuroblastoma/*genetics
ras Proteins/*genetics
Anaplastic Lymphoma Kinase ; Animals ; Benzimidazoles/pharmacology ; Blotting, Western ; Cell Line, Tumor ; Child ; Child, Preschool ; Chromosome Aberrations ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; Cyclin-Dependent Kinase Inhibitor p16/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; HEK293 Cells ; Humans ; Infant ; Male ; Mice, SCID ; Mitogen-Activated Protein Kinases/metabolism ; Neuroblastoma/drug therapy ; Neuroblastoma/pathology ; Phosphorylation/drug effects ; Receptor Protein-Tyrosine Kinases/genetics ; Receptor Protein-Tyrosine Kinases/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Xenograft Model Antitumor Assays ; ras Proteins/metabolism
Czasopismo naukowe
Tytuł:
Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group.
Autorzy:
Vujkovic M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: .
Attiyeh EF; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Horn M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Goodman EK; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ding Y; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kavcic M; University Medical Centre, Ljubljana, Slovenia.
Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Gerbing RB; Children's Oncology Group, Monrovia, CA, USA.
Hirsch B; University of Minnesota, Minneapolis, MN, USA.
Raimondi S; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Gamis AS; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Aplenc R; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Cancer genetics [Cancer Genet] 2015 Jul-Aug; Vol. 208 (7-8), pp. 408-13. Date of Electronic Publication: 2015 May 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
DNA Copy Number Variations*
Loss of Heterozygosity*
Genome-Wide Association Study/*methods
Genotyping Techniques/*methods
Leukemia, Myeloid/*genetics
Acute Disease ; Female ; Genotype ; Humans ; Male ; Microarray Analysis/methods ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
A Case of Adenovirus Viremia in a Pediatric Liver Transplant Recipient With Neutropenia and Lymphopenia: Who and When Should We Treat?
Autorzy:
Patel RR; Division of Infectious Diseases.
Hodinka RL; Division of Clinical Virology Laboratory, The Children's Hospital of Philadelphia, Pennsylvania; Departments of Division of Pathology, and the.
Kajon AE; Division of Infectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Klieger S; Division of Infectious Diseases Division of Center for Pediatric Clinical Effectiveness, and the.
Oikonomopoulou Z; Division of Infectious Diseases.
Petersen H; Division of Infectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico.
Rand E; Division of Gastroenterology and.
Attiyeh EF; Division of Oncology, the.
Fisher BT; Division of Infectious Diseases Division of Center for Pediatric Clinical Effectiveness, and the Division of Center for Clinical Epidemiology and Biostatistics, The Perelman School of Medicine at the University of Pennsylvania School of Medicine, Philadelphia.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2015 Mar; Vol. 4 (1), pp. e1-5. Date of Electronic Publication: 2013 Dec 10.
Typ publikacji:
Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Transplantation*
Adenovirus Infections, Human/*therapy
Adenoviruses, Human/*physiology
Immunosuppressive Agents/*administration & dosage
Lymphopenia/*therapy
Neutropenia/*therapy
Viremia/*therapy
Adenovirus Infections, Human/complications ; Adenovirus Infections, Human/metabolism ; Adenovirus Infections, Human/virology ; Child, Preschool ; Hepatoblastoma/complications ; Hepatoblastoma/metabolism ; Hepatoblastoma/surgery ; Humans ; Immunocompromised Host ; Liver Neoplasms/complications ; Liver Neoplasms/metabolism ; Liver Neoplasms/surgery ; Lymphopenia/etiology ; Lymphopenia/metabolism ; Male ; Neutropenia/etiology ; Neutropenia/metabolism ; Viral Load ; Viremia/complications ; Viremia/metabolism
Czasopismo naukowe
Tytuł:
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
Autorzy:
Diskin SJ; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Capasso M
Schnepp RW
Cole KA
Attiyeh EF
Hou C
Diamond M
Carpenter EL
Winter C
Lee H
Jagannathan J
Latorre V
Iolascon A
Hakonarson H
Devoto M
Maris JM
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2012 Oct; Vol. 44 (10), pp. 1126-30. Date of Electronic Publication: 2012 Sep 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Polymorphism, Single Nucleotide*
DNA-Binding Proteins/*genetics
Neuroblastoma/*genetics
Ubiquitin-Protein Ligases/*genetics
Case-Control Studies ; Cell Line, Tumor ; Cell Proliferation ; Chromosomes, Human, Pair 6 ; Cohort Studies ; DNA-Binding Proteins/metabolism ; Gene Expression ; Gene Frequency ; Gene Knockdown Techniques ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Infant ; Kaplan-Meier Estimate ; Linkage Disequilibrium ; Neuroblastoma/metabolism ; Neuroblastoma/mortality ; Oligonucleotide Array Sequence Analysis ; RNA Interference ; RNA-Binding Proteins ; Sequence Analysis, DNA ; Transcriptome ; Ubiquitin-Protein Ligases/metabolism
Czasopismo naukowe
Tytuł:
Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
Autorzy:
Nguyen le B; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Diskin SJ
Capasso M
Wang K
Diamond MA
Glessner J
Kim C
Attiyeh EF
Mosse YP
Cole K
Iolascon A
Devoto M
Hakonarson H
Li HK
Maris JM
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2011 Mar; Vol. 7 (3), pp. e1002026. Date of Electronic Publication: 2011 Mar 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Loci*
Genome-Wide Association Study*
Phenotype*
Genetic Predisposition to Disease/*genetics
Neuroblastoma/*genetics
Algorithms ; Child, Preschool ; Haplotypes ; Humans ; Infant ; Neoplasm Staging ; Neuroblastoma/pathology ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
Autorzy:
Deyell RJ; Division of Oncology, Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, USA.
Attiyeh EF
Pokaż więcej
Źródło:
Cancer genetics [Cancer Genet] 2011 Mar; Vol. 204 (3), pp. 113-21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neuroblastoma/*genetics
Child ; Child, Preschool ; Gene Expression Regulation, Neoplastic ; Genome-Wide Association Study ; Genomics ; Humans ; Infant ; Oligonucleotide Array Sequence Analysis ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Autorzy:
Capasso M; Division of Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Devoto M
Hou C
Asgharzadeh S
Glessner JT
Attiyeh EF
Mosse YP
Kim C
Diskin SJ
Cole KA
Bosse K
Diamond M
Laudenslager M
Winter C
Bradfield JP
Scott RH
Jagannathan J
Garris M
McConville C
London WB
Seeger RC
Grant SF
Li H
Rahman N
Rappaport E
Hakonarson H
Maris JM
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2009 Jun; Vol. 41 (6), pp. 718-23. Date of Electronic Publication: 2009 May 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Variation*
Neuroblastoma/*genetics
Polymorphism, Single Nucleotide/*genetics
Tumor Suppressor Proteins/*genetics
Ubiquitin-Protein Ligases/*genetics
Chromosomes, Human, Pair 6/genetics ; Genetic Predisposition to Disease ; Genotype ; Heterozygote ; Humans ; Neuroblastoma/epidemiology ; Odds Ratio ; Risk Factors
Czasopismo naukowe
Tytuł:
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Autorzy:
Park JR; Department of Pediatrics, Children's Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA. />Villablanca JG
London WB
Gerbing RB
Haas-Kogan D
Adkins ES
Attiyeh EF
Maris JM
Seeger RC
Reynolds CP
Matthay KK
Pokaż więcej
Corporate Authors:
Children's Oncology Group
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2009 Jan; Vol. 52 (1), pp. 44-50.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Bone Marrow Transplantation/*methods
Isotretinoin/*therapeutic use
Neuroblastoma/*therapy
Bone Marrow Purging ; Cisplatin ; Combined Modality Therapy ; Cyclophosphamide ; Doxorubicin ; Etoposide ; Humans ; Infant ; Neuroblastoma/mortality ; Radiotherapy ; Risk ; Survival Analysis ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Identification of ALK as a major familial neuroblastoma predisposition gene.
Autorzy:
Mossé YP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Laudenslager M
Longo L
Cole KA
Wood A
Attiyeh EF
Laquaglia MJ
Sennett R
Lynch JE
Perri P
Laureys G
Speleman F
Kim C
Hou C
Hakonarson H
Torkamani A
Schork NJ
Brodeur GM
Tonini GP
Rappaport E
Devoto M
Maris JM
Pokaż więcej
Źródło:
Nature [Nature] 2008 Oct 16; Vol. 455 (7215), pp. 930-5. Date of Electronic Publication: 2008 Aug 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease/*genetics
Mutation/*genetics
Neuroblastoma/*enzymology
Neuroblastoma/*genetics
Protein-Tyrosine Kinases/*genetics
Anaplastic Lymphoma Kinase ; Base Sequence ; Cell Line, Tumor ; Child ; Chromosomes, Human, Pair 2/genetics ; Female ; Gene Dosage ; Gene Expression Regulation, Neoplastic ; Germ-Line Mutation/genetics ; Humans ; Male ; Models, Molecular ; Molecular Sequence Data ; Pedigree ; Phosphorylation ; Protein Structure, Tertiary ; Protein-Tyrosine Kinases/chemistry ; Protein-Tyrosine Kinases/deficiency ; Receptor Protein-Tyrosine Kinases
Czasopismo naukowe
Tytuł:
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Autorzy:
Mosse YP; Division of Oncology, Children's Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. />Diskin SJ
Wasserman N
Rinaldi K
Attiyeh EF
Cole K
Jagannathan J
Bhambhani K
Winter C
Maris JM
Pokaż więcej
Źródło:
Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2007 Oct; Vol. 46 (10), pp. 936-49.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
DNA, Neoplasm/*genetics
Gene Dosage/*genetics
Neuroblastoma/*genetics
CCCTC-Binding Factor ; Chromosomes, Human, Pair 11/genetics ; DNA Methylation ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Humans ; In Situ Hybridization, Fluorescence ; Infant ; Insulin-Like Growth Factor II ; Loss of Heterozygosity ; Neuroblastoma/metabolism ; Nucleic Acid Hybridization ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Phenotype ; Prognosis ; Proteins/genetics ; Proteins/metabolism ; Repressor Proteins/genetics ; Repressor Proteins/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies